Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2010
08/10/2010US7771970 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture
08/10/2010US7771969 Methods for obtaining antibodies
08/10/2010US7771967 Nucleic acid encoding apolipoprotein E-I3
08/10/2010US7771966 Polypeptide cleavage process
08/10/2010US7771955 Affinity membrane for capture of a target biomolecule and formation thereof by site-directed immobilization of a capture biomolecule
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771762 Ultrafiltration pretreatment; adjustment of pH; enzyme treatment ; deactivation of enzyme
08/10/2010US7771728 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders
08/10/2010US7771725 vaccine; for dengue, yellow fever, West Nile , chikungunya, Ross River, O'nyong-nyong, and Mayaro viruses
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771720 bind and neutralize Plasminogen Activator Inhibitor-1 (PAI-1) by converting PAI-1 to its latent form or increasing proteolytic cleavage; treating a fibrotic condition; inhibits accumulation of extracellular matrix (ECM)
08/10/2010US7771719 Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
08/10/2010US7771714 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2351589C Plant diacylglycerol acyltransferases
08/10/2010CA2253239C Antibodies against interferon alpha/beta receptor
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/10/2010CA2223491C Cdr-grafted anti-tissue factor antibodies and methods of use thereof
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/05/2010WO2010087994A2 Methods for ligation and uses thereof
08/05/2010WO2010087344A1 Method for transforming schizosaccharomyces pombe, transformant of schizosaccharomyces pombe, and method for producing heterologous protein
08/05/2010WO2010060100A3 Antibodies directed against calcium channel subunit alpha2/delta and mehtods using same
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199383 Novel Bacillus Thuringiensis Gene with Coleopteran Activity
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100199365 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms
08/05/2010US20100199363 Enzymes for degrading herbicides
08/05/2010US20100197897 Binding molecules
08/05/2010US20100197896 Functional humanization of complementarity determining regions (cdrs)
08/05/2010US20100197895 Antibodies to human tumor necrosis factor receptor
08/05/2010US20100197578 Demannosylated recombinant factor viii [[vii]] for the treatment of patients with haemophilia a
08/05/2010US20100197568 Protective hydrocolloid for active ingredients
08/05/2010US20100197556 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
08/05/2010US20100197011 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
08/05/2010US20100196988 Bioreactive Agents
08/05/2010US20100196963 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
08/05/2010US20100196962 Il-6 receptor il-6 direct fusion protein
08/05/2010US20100196961 Variable tangential flow filtration
08/05/2010US20100196960 Transporter genes oatp-b, c, d, and e
08/05/2010US20100196959 Alleles of the opca gene from coryneform bacteria
08/05/2010US20100196958 Reduced Phosphotransferase System Activity in Bacteria
08/05/2010US20100196957 Cloning and characterization of 5' flanking regions of a human aggrecanase-1 gene
08/05/2010US20100196956 Novel constitutive strong promoter and use thereof
08/05/2010US20100196955 Scaleable Manufacturing Process for Cysteine Endoprotease B, Isoform 2
08/05/2010US20100196954 Modified Endoglucanase II and Methods of Use
08/05/2010US20100196953 Cleavage of precursors of insulins by a variant of trypsin
08/05/2010US20100196952 Method for preparative in vitro protein biosynthesis
08/05/2010US20100196951 Antitoxin Destabilization Technology
08/05/2010US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer
08/05/2010US20100196524 Novel peptides and methods for producing them
08/05/2010US20100196423 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes
08/05/2010US20100196421 clostridial neurotoxin propeptide which has a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain regions; intermediate region has a highly specific protease cleavage site
08/05/2010US20100196419 Enhancement of glycoprotein incorporation into virus-like particles
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196410 Streptococcus pneumoniae Antigens and Vaccines
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196395 Anti-igf antibodies
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody
08/05/2010US20100196383 Connective Tissue Growth Factor (CTGF-3)
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196371 Method of modulating the activity of functional immune molecules
08/05/2010US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
08/05/2010US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196302 Keratin Hydrolysates, Process for Their Production and Cosmetic Composition Containing the Same
08/04/2010EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines
08/04/2010EP2213747A1 Method for producing membrane protein
08/04/2010EP2213746A1 Cell for use in the production of exogenous protein, and production process using the cell
08/04/2010EP2213745A1 Improved bacillus host cell
08/04/2010EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
08/04/2010EP2212432A2 Fully human anti-vegf antibodies and methods of using
08/04/2010EP2212431A2 Antibodies to irem-1
08/04/2010EP2212422A1 Methods and compositions
08/04/2010EP1572931B1 Methods and compositions for modulating and detecting wisp activity
08/04/2010CN101792782A Preparation process for producing malt syrup and rice protein from rice-washing water
08/04/2010CN101792767A Fully artificial synthesis and water soluble expression of porcine alpha-interferon gene
08/04/2010CN101792766A Method for producing porcine growth hormones and special DNA fragment thereof
08/04/2010CN101792738A Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof
08/04/2010CN101792732A Techniques for growth and differentiation of human pluripotent stem cells
08/04/2010CN101792382A Method for preparing disinfected-decolorized fish-squamosum organic acid calcium and non-denatured collagen
08/04/2010CN101270344B Bacillus subtillis for preventing and controlling cole sclerotium and antibioticsubstance separation
08/03/2010US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
08/03/2010US7767793 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases
08/03/2010US7767792 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy
08/03/2010US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
08/03/2010US7767789 Truncated proteins as cancer markers
08/03/2010US7767787 Substance for obtaining highly effective tumor medications as well as a process
08/03/2010US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration
08/03/2010US7767449 Methods using modified vaccinia virus
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767428 Nucleotide sequences coding transferase for use in production of thebaine
08/03/2010US7767418 Expression vector comprising nucleotide sequences coding immunoglobulin fusion comprising transient receptor potential cation channel for use in identifying modulator for treatment and prevention of nervous system disorders
08/03/2010US7767417 Prenyl-electrostatic switch, and methods of use
08/03/2010US7767415 Removal antigens from blood
08/03/2010US7767403 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer
08/03/2010US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
08/03/2010US7767211 S.aureus polypeptides
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1125